What are Mission Vision & Core Values of Novozymes Company?

How is Novozymes driving biological transformation today?

Novozymes anchors strategy in biological innovation to replace carbon‑intensive chemistry, guiding R&D, capital allocation and global expansion after its 2024 merger into Novonesis. By mid‑2025 it holds about 45% of the industrial enzyme market.

These mission, vision and core values prioritize sustainable biosolutions, scalable fermentation infrastructure and collaborative research hubs to align investments with long‑term biological transformation goals.

What are Mission Vision & Core Values of Novozymes Company? Novozymes Porter's Five Forces Analysis

Novozymes mission centers on delivering better business with biology by replacing chemicals and reducing energy and waste for global industries, targeting CPG, agriculture and food manufacturers with scalable biosolutions that cut emissions and costs.

Mission focus

Drive decarbonization and resource efficiency through enzyme and microbial solutions.

Target customers

Serve multinationals in consumer goods, textile mills, food processors and farmers worldwide.

Value proposition

Reduce raw-material waste, lower energy use and eliminate harsh chemicals from supply chains.

Innovation examples

2025 textile enzymes deliver stone-wash effects with far less water; carbon-capture microbes convert emissions to feedstocks.

Market scope

Global reach with emphasis on high-growth segments like industrial decarbonization and human health probiotics.

Strategic impact

Positions the company to capture rising demand for sustainable biosolutions and improve partners’ margins.

Novozymes strategic direction emphasizes proprietary biological toolkits that solve customer pain points while advancing sustainability; in 2024 the company reported enzyme sales growth of ~8% and R&D spend near 8–9% of revenue, underlining investment in innovation. Growth Strategy of Novozymes

Companys’s vision is to be the leading biosolutions partner for a healthier planet, driving a bio-based economy with biological precision, targeting 6–8% organic growth and net-zero value-chain emissions by 2050.

Vision Focus

To lead the transition from chemical to biological solutions across food, agriculture, industrial and pharma sectors.

Financial Trajectory

Targets 6–8% organic revenue growth and sustains an EBITDA margin above 30% to fund R&D.

R&D Investment

Invests over 10% of annual revenue in R&D, leveraging >700 products and thousands of patents.

Sustainability Goal

Committed to net-zero across the value chain by 2050 as part of its sustainability mission statement.

Market Position

Global reach and multi-sector scope enable disruption of fossil-fuel based industries through biosolutions.

Strategic Direction

Uses strong margins and cash flow to scale biologically driven innovation and commercial adoption.

To be the leading biosolutions partner for a healthier planet, replacing chemical paradigms with biological precision while pursuing 6–8% organic growth and net-zero value-chain emissions by 2050. Read more about ownership and governance Owners & Shareholders of Novozymes

Novozymes core values guide decision-making, innovation and stakeholder engagement across the company; they shape culture and commercial priorities while supporting the Novozymes mission and Novozymes vision. These values drive R&D choices, partnerships and sustainability targets as the company pursues biological solutions for industry.

Open

Transparency and knowledge sharing underpin an open-innovation model, enabling collaboration with startups and academia to accelerate discovery and build trust with regulators and customers.

Courageous

Willingness to invest in high-risk, high-impact technologies drives initiatives such as 2025 trials on nitrogen‑fixing microbes targeting disruption of the multi‑billion dollar fertilizer market.

Collaborative

Cross-functional squads combining biology, data science and commercial teams enable faster go‑to‑market and bespoke co‑development with customers, reflecting Novozymes company purpose and strategic direction.

Passionate

Purpose‑driven staff prioritize environmental impact alongside profit, attracting top scientific talent and supporting sustainability targets such as emissions reductions tied to product adoption.

Read how Novozymes mission and vision influence strategic decisions and R&D priorities next; see practical examples and metrics in the following chapter and this analysis of market fit: Target Market of Novozymes

Values: The company operates under four core values that define its culture and business conduct as of 2025; Open, Courageous, Collaborative, Passionate.

The mission and vision shape strategic priorities, capital allocation and partnerships across the organization, directing investments toward scalable biosolutions that improve human and planetary health. These guiding statements inform product roadmaps, market entry and sustainability targets used by leadership to measure impact.

Novozymes mission, vision & core values

Concise framing of purpose: harnessing biology to create sustainable solutions for industry and society.

• The mission prioritizes better business through biology, targeting sustainability and productivity gains.
• The vision emphasizes a healthier planet enabled by biological innovation.
• Core values center on collaboration, integrity and curiosity to drive long-term value.
• Strategy metrics link products to environmental outcomes, including avoided emissions.

Mission drives investments

Mission-led funding prioritized precision fermentation facilities for animal-free proteins to scale sustainable food solutions.

Vision shapes partnerships

Vision-aligned collaborations include energy firms to develop second-generation biofuels, reducing lifecycle emissions.

Market expansion strategy

Focus on emerging markets in Asia and Latin America where agricultural modernization creates demand for biosolutions.

Measured impact

Success tracked by environmental metrics; most recent reporting shows customers avoided over 60 million tons of CO2 using company products.

Leadership messaging

CEO communications emphasize biosolutions as key to a sustainable future, reinforcing strategic alignment with purpose.

Values in culture

Core values influence hiring, R&D priorities and customer engagement to sustain innovation and ethical practice.

Read how these guiding statements inform strategic changes and proposed core improvements next: Competitors Landscape of Novozymes

Four targeted improvements can sharpen Novozymes' mission and vision to match the 2025 biotech landscape and stakeholder expectations. Each improvement focuses on clarity, digital integration, regenerative ambition, and measurable commitments tied to market and sustainability metrics.

Embed 'data-driven' and 'digital-first' language

Revise the Novozymes mission to explicitly reference digital biology and AI to reflect that software-enabled design contributes to faster R&D cycles and cost efficiencies, supporting claims that AI accelerates protein engineering timelines by up to 30–50% in recent industry studies.

Shift vision from 'sustainability' to 'regeneration'

Update the Novozymes vision toward regeneration—for example, 'To lead the biological revolution that regenerates the planet's resources'—aligning with investor and consumer demand for positive-impact targets and positioning the company above peers emphasizing incremental sustainability.

Introduce measurable, time-bound targets

Add clear KPIs to Novozymes mission and strategic direction—such as percentage reductions in carbon intensity, percentage of revenue from regenerative solutions, or targeted 2030 metrics—to improve accountability and investor transparency.

Elevate core values to guide AI ethics and partnerships

Expand Novozymes core values to include explicit AI ethics, data stewardship, and open-science collaboration principles to manage risk as generative models and bioinformatics become central to product innovation.

Improvements: While the current Novozymes mission and Novozymes vision are strong, there are opportunities for refinement to better reflect the 2025 technological landscape. The mission could be strengthened by explicitly mentioning the role of artificial intelligence and digital biology; as the company increasingly uses generative AI to design novel proteins, incorporating a 'digital-first' or 'data-driven' component into the mission would better align with current industry trends where the laboratory and the computer are becoming one. Furthermore, compared to some competitors who have adopted more aggressive 'nature-positive' language, the vision could be updated to move beyond 'sustainability' toward 'regeneration'—a suggested refinement is 'To lead the biological revolution that regenerates the planet's resources'—aligning with evolving consumer behaviors and investor demands for companies to not just do 'less harm' but to actively 'do more good.' These growth opportunities would allow the company to maintain its leadership position as the biosolutions market becomes increasingly crowded with agile biotech startups and diversifying chemical giants. For background on the company evolution, see Brief History of Novozymes